Endotis starts phase-2a trial of reversible anticoagulant for open-heart surgery: http://finance.yahoo.com/news/Endotis-Intiates-Phase-IIa-bw-868822504.html?x=0&.v=1 Data will be available by the end of 2011. Endotis is a private biotech company based in Paris.